Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and ...

Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.

Tempus AI (TEM) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR IVD device. The ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510 (k) clearance from the U.S. Food and ...

SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its ...

“GOAST v4.0 breaks bioinformatics bottlenecks by combining Lenovo’s HPC expertise with genomics innovation,” said Sumir Bhatia, President, Lenovo ISG Asia Pacific. “With this leap in performance and ...

Let us know. Catch every headline in your inbox ...

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.

Modern agriculture faces mounting challenges from climate change, soil degradation, and rising biotic and abiotic stresses, ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Qiagen N.V. is one of ...

The T7+ integrates MGI's proprietary DNBSEQ™ technology with next-generation fluidics, optics, and bioinformatics, creating a platform that is faster, smarter, and more versatile than ever before. The ...